Skip to content
10-Q

Quarterly Report

Oyster Point Pharma, Inc.

0001720725-22-000072

← back to feed
Filed
Aug 11, 2022 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2022 · Aug 5, 2022 26.83M sh
Shares Diluted Q2 2022 · Jun 30, 2022 26.74M sh
Shares Diluted Q2 2022 · Jun 30, 2022 26.69M sh
Shares Diluted Q2 2022 · Jun 30, 2021 25.99M sh
Shares Diluted Q2 2022 · Jun 30, 2021 25.96M sh
Capex Q2 2022 · Jun 30, 2022 $203K
Capex Q2 2022 · Jun 30, 2021 $994K
Operating Cash Flow Q2 2022 · Jun 30, 2022 −$88.54M
Operating Cash Flow Q2 2022 · Jun 30, 2021 −$37.09M
Long Term Debt Q2 2022 · Jun 30, 2022 $91.44M
Long Term Debt Q2 2022 · Dec 31, 2021 $89.82M
Cash And Equivalents Q2 2022 · Jun 30, 2022 $104.88M
Cash And Equivalents Q2 2022 · Dec 31, 2021 $193.37M
Cash And Equivalents Q2 2022 · Jun 30, 2021 $154.81M
Stockholders Equity Q2 2022 · Jun 30, 2022 $10.78M
Stockholders Equity Q2 2022 · Mar 31, 2022 $55.99M
Stockholders Equity Q2 2022 · Dec 31, 2021 $99.54M
Stockholders Equity Q2 2022 · Jun 30, 2021 $151.78M
Stockholders Equity Q2 2022 · Mar 31, 2021 $170.65M
Stockholders Equity Q2 2022 · Dec 31, 2020 $186.66M
Current Liabilities Q2 2022 · Jun 30, 2022 $31.13M
Current Liabilities Q2 2022 · Dec 31, 2021 $28.8M
Total Liabilities Q2 2022 · Jun 30, 2022 $133.16M
Total Liabilities Q2 2022 · Dec 31, 2021 $123.08M
Current Assets Q2 2022 · Jun 30, 2022 $132.72M
Current Assets Q2 2022 · Dec 31, 2021 $215.25M
Total Assets Q2 2022 · Jun 30, 2022 $143.94M
Total Assets Q2 2022 · Dec 31, 2021 $222.62M
Eps Diluted Q2 2022 · Jun 30, 2022 −$1.87
Eps Diluted Q2 2022 · Jun 30, 2022 −$3.67
Eps Diluted Q2 2022 · Jun 30, 2021 −$0.85
Eps Diluted Q2 2022 · Jun 30, 2021 −$1.58
Eps Basic Q2 2022 · Jun 30, 2022 −$1.87
Eps Basic Q2 2022 · Jun 30, 2022 −$3.67
Eps Basic Q2 2022 · Jun 30, 2021 −$0.85
Eps Basic Q2 2022 · Jun 30, 2021 −$1.58
Sga Expense Q2 2022 · Jun 30, 2022 $14M
Sga Expense Q2 2022 · Jun 30, 2022 $26.93M
Sga Expense restated Q2 2022 · Jun 30, 2021 $9.09M
Sga Expense restated Q2 2022 · Jun 30, 2021 $17.61M
Rd Expense Q2 2022 · Jun 30, 2022 $4.66M
Rd Expense Q2 2022 · Jun 30, 2022 $9.35M
Rd Expense Q2 2022 · Jun 30, 2021 $6.73M
Rd Expense Q2 2022 · Jun 30, 2021 $12.56M
Net Income Q2 2022 · Jun 30, 2022 −$49.94M
Net Income Q2 2022 · Jun 30, 2022 −$97.83M
Net Income Q2 2022 · Mar 31, 2022 −$47.89M
Net Income Q2 2022 · Jun 30, 2021 −$22.02M
Net Income Q2 2022 · Jun 30, 2021 −$40.93M
Net Income Q2 2022 · Mar 31, 2021 −$18.91M
Operating Income Q2 2022 · Jun 30, 2022 −$43.39M
Operating Income Q2 2022 · Jun 30, 2022 −$85.6M
Operating Income Q2 2022 · Jun 30, 2021 −$22.03M
Operating Income Q2 2022 · Jun 30, 2021 −$40.95M
Cost Of Revenue Q2 2022 · Jun 30, 2022 $1.31M
Cost Of Revenue Q2 2022 · Jun 30, 2022 $1.65M
Cost Of Revenue Q2 2022 · Jun 30, 2021 $0
Cost Of Revenue Q2 2022 · Jun 30, 2021 $0
Revenue Q2 2022 · Jun 30, 2022 $4.69M
Revenue Q2 2022 · Jun 30, 2022 $7.4M
Revenue Q2 2022 · Jun 30, 2021 $0
Revenue Q2 2022 · Jun 30, 2021 $0